Insulation of a conditionally expressed transgene in an adenoviral vector
- 1 June 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (6), 1192-1197
- https://doi.org/10.1038/sj.gt.3300910
Abstract
Replication-defective recombinant adenoviruses provide an efficient system for in vivo gene transfer and numerous studies have demonstrated that this vector can accommodate tissue-specific promoters to restrict the expression of a transgene to a particular subset of cells. However, in some cases the selectivity of expression is lost when the tissue-specific promoter is placed in an adenoviral environment. In an attempt to restore the conditionality of expression of the transgene driven by the human ERBB2 promoter, we have flanked the expression cassette in 5′ and 3′ orientations with a 250 bp sequence containing the bovine growth hormone transcriptional stop signal for cloning into a recombinant adenovirus. The data presented here clearly demonstrate that these ‘insulator’ elements are able to restrict the expression of the transgene (herpes simplex thymidine kinase) to ERBB2-expressing cells and therefore to restore the selectivity mediated by the ERBB2 promoter. This approach could be generally useful to insulate expression cassettes in adenoviral vectors.Keywords
This publication has 13 references indexed in Scilit:
- Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytesAmerican Journal of Physiology-Cell Physiology, 1998
- Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Journal of Clinical Investigation, 1997
- Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancerGene Therapy, 1997
- Modulation of the Specificity and Activity of a Cellular Promoter in an Adenoviral VectorHuman Gene Therapy, 1997
- Targeted gene delivery by tropism-modified adenoviral vectorsNature Biotechnology, 1996
- A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.The EMBO Journal, 1993
- Gene therapy for cancerThe Lancet, 1992
- Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancerBritish Journal of Cancer, 1991
- The c‐erbB‐2 proto‐oncogene in human pancreatic cancerThe Journal of Pathology, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987